These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9505825)

  • 21. A comparison of HLA genotype with inflammation in uveal melanoma.
    van Essen TH; Bronkhorst IH; Maat W; Verduyn W; Roelen DL; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2640-6. PubMed ID: 22447860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
    Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of HLA class II antigens on human uveal melanoma cells after in vivo X-ray irradiation.
    Jager MJ; van der Pol JP; de Wolff-Rouendaal D; de Jong PT; Ruiter DJ
    Am J Ophthalmol; 1988 Jan; 105(1):78-86. PubMed ID: 3276205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA class II antigen expression in uveal melanoma: correlation with clinicopathological features.
    Krishnakumar S; Abhyankar D; Lakshmi SA; Shanmugam MP; Pushparaj V; Biswas J
    Exp Eye Res; 2003 Aug; 77(2):175-80. PubMed ID: 12873447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal HLA class I, II, and MICA gene distribution in uveal melanoma.
    Metzelaar-Blok JA; Hurks HM; Naipal A; De Lange P; Keunen JE; Claas FH; Doxiadis II; Jager MJ
    Mol Vis; 2005 Dec; 11():1166-72. PubMed ID: 16379028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
    Krishna Y; McCarthy C; Kalirai H; Coupland SE
    Hum Pathol; 2017 Aug; 66():159-166. PubMed ID: 28655639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
    Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of transpupillary thermotherapy on immunological parameters and apoptosis in a case of primary uveal melanoma.
    Schurmans LR; Blom DJ; De Waard-Siebinga I; Keunen JE; Prause JU; Jager MJ
    Melanoma Res; 1999 Jun; 9(3):297-302. PubMed ID: 10465586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
    Ma D; Niederkorn JY
    Immunology; 1995 Oct; 86(2):263-9. PubMed ID: 7490128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.
    van Houdt IS; Sluijter BJ; Moesbergen LM; Vos WM; de Gruijl TD; Molenkamp BG; van den Eertwegh AJ; Hooijberg E; van Leeuwen PA; Meijer CJ; Oudejans JJ
    Int J Cancer; 2008 Aug; 123(3):609-15. PubMed ID: 18498132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanomas that develop within the eye inhibit lymphocyte proliferation.
    Verbik DJ; Murray TG; Tran JM; Ksander BR
    Int J Cancer; 1997 Nov; 73(4):470-8. PubMed ID: 9389558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas.
    López-Nevot MA; Garcia E; Romero C; Oliva MR; Serrano S; Garrido F
    Exp Clin Immunogenet; 1988; 5(4):203-12. PubMed ID: 3078572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.
    Ruiz-Cabello F; Lopez Nevot MA; Gutierrez J; Oliva MR; Romero C; Ferron A; Esteban F; Huelin C; Piris MA; Rivas C
    Clin Exp Metastasis; 1989; 7(2):213-26. PubMed ID: 2493352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell surface antigens of human uveal melanoma identified by monoclonal antibodies.
    Kalafut F; Kusenda J; Novotná L; Cernák A
    Czech Med; 1988; 11(2):73-80. PubMed ID: 3137006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HLA class I antigen expression correlates with histological cell type in uveal melanoma].
    Dithmar S; Crowder J; Jager MJ; Vigniswaran N; Grossniklaus HE
    Ophthalmologe; 2002 Aug; 99(8):625-8. PubMed ID: 12227276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic dynamics of tumor progression in human malignant melanoma.
    Bröcker EB; Suter L; Brüggen J; Ruiter DJ; Macher E; Sorg C
    Int J Cancer; 1985 Jul; 36(1):29-35. PubMed ID: 3860479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.